Emerging therapies for endometriosis

Reflections
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Emerging therapies for endometriosis
Like

Related Content

Fertility and Sterility
Fertility and Sterility Fertility and Sterility

Emerging therapies for endometriosis

Although endometriosis is one of the most common gynecologic diseases, treatment options have long been limited. Commonly used medications include nonsteroidal antiinflammatory drugs, progestins (including those in oral contraceptives), danazol, and GnRH agonists. Danazol and GnRH agonist use are as…

VOLUME 115, ISSUE 2, P317-318

Author:

Hugh S. Taylor, M.D.

Abstract:

Reflections on "Relugolix, an oral GnRH receptor antagonist, reduces endometriosis-associated pain in a dose-response manner: a randomized, double-blind, placebo-controlled study" by Osuga et al.

Read the full text here. 

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Recommended Content